Literature DB >> 12846264

The threat from the pink corner.

David M Livermore1.   

Abstract

In terms of numbers of isolates, the greatest present resistance problems arise with gram-positive pathogens (which stain purple/black in Gram's method), especially methicillin-resistant Staphylococcus aureus (MRSA). But, is the MRSA problem--by its size--blinding us to something ultimately more dangerous: the slow emergence of gram-negative pathogens (which stain pink) with resistance to all reliable antibiotics? Although presently rare, 'pan-resistant' gram-negative bacteria--predominantly strains of Pseudomonas aeruginosa and Acinetobacter baumannii--have more comprehensive resistance than any gram-positive pathogen. They already pose treatment problems in compromised hospital patients, especially in specialist units, as well in particular groups, such as cystic fibrosis patents. Disturbingly, there is a near-total lack of developmental antibiotics active against gram-negative pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846264     DOI: 10.1080/07853890310001609

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  23 in total

1.  Novel mechanism for fluoroquinolone resistance in Acinetobacter baumannii.

Authors:  Sunil D Saroj; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

2.  Modification of Salmonella Lipopolysaccharides Prevents the Outer Membrane Penetration of Novobiocin.

Authors:  Thatyane M Nobre; Michael W Martynowycz; Konstantin Andreev; Ivan Kuzmenko; Hiroshi Nikaido; David Gidalevitz
Journal:  Biophys J       Date:  2015-12-15       Impact factor: 4.033

3.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Authors:  Maria Virginia Villegas; Juan Nicolas Kattan; Adriana Correa; Karen Lolans; Ana Maria Guzman; Neil Woodford; David Livermore; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

6.  Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors:  Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 7.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

8.  NH-1,2,3-Triazole-based Inhibitors of the VIM-2 Metallo-β-Lactamase: Synthesis and Structure-Activity Studies.

Authors:  Timo Weide; S Adrian Saldanha; Dmitriy Minond; Timothy P Spicer; Joseph R Fotsing; Michael Spaargaren; Jean-Marie Frère; Carine Bebrone; K Barry Sharpless; Peter S Hodder; Valery V Fokin
Journal:  ACS Med Chem Lett       Date:  2010-07-08       Impact factor: 4.345

9.  Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.

Authors:  Phillip J Bergen; Alan Forrest; Jürgen B Bulitta; Brian T Tsuji; Hanna E Sidjabat; David L Paterson; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

10.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.